OncoBay Clinical is a niche CRO focused on Immunotherapy with a specialization in cellular therapy trial operations. As a subsidiary of Moffitt Cancer center we leverage the scientific and manufacturing infrastructure expertise and apply that directly to full service commercial CRO operations. OncoBay’s solution is more than just a minor enhancement to the expected conventional CRO process, we’ve pioneered an innovative approach. Built on a cellular therapy focus, streamlined testing framework, highly trained site network and a dedicated team of experienced professionals, OncoBay offers custom-curated services for IO clinical trials. This is IO research, reimagined.